Orthofix Medical (OFIX) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthofix Medical | 375.38 Mn | 254.51 Mn | 139.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.17% |
| Dec 31, 2025 | -1.81% |
| Sep 30, 2025 | -33.23% |
| Jun 30, 2025 | -19.45% |
| Mar 31, 2025 | -38.37% |
| Dec 31, 2024 | 17.86% |
| Sep 30, 2024 | -5.08% |
| Jun 30, 2024 | -16.71% |
| Mar 31, 2024 | -38.93% |
| Dec 31, 2023 | -27.35% |
| Sep 30, 2023 | -30.49% |
| Jun 30, 2023 | -27.05% |
| Mar 31, 2023 | -48.07% |
| Dec 31, 2022 | -16.81% |
| Sep 30, 2022 | -21.82% |
| Jun 30, 2022 | -41.17% |
| Mar 31, 2022 | 2.26% |
| Dec 31, 2021 | -20.22% |
| Sep 30, 2021 | -22.18% |
| Jun 30, 2021 | -20.29% |
| Mar 31, 2021 | -6.01% |
| Dec 31, 2020 | 11.17% |
| Sep 30, 2020 | 13.26% |
| Jun 30, 2020 | 53.96% |
| Mar 31, 2020 | 39.23% |
| Dec 31, 2019 | -4.59% |
| Sep 30, 2019 | -10.04% |
| Jun 30, 2019 | -29.61% |
| Mar 31, 2019 | 16.39% |
| Dec 31, 2018 | 11.80% |
| Sep 30, 2018 | 1.44% |
| Jun 30, 2018 | 2.11% |
| Mar 31, 2018 | -22.05% |
| Dec 31, 2017 | 19.05% |
| Sep 30, 2017 | 12.39% |
| Jun 30, 2017 | 4.44% |
| Mar 31, 2017 | -18.57% |
| Dec 31, 2016 | 0.22% |
| Sep 30, 2016 | 5.79% |
| Jun 30, 2016 | 79.59% |
| Mar 31, 2016 | -16.09% |
| Dec 31, 2015 | 25.05% |
| Sep 30, 2015 | 14.91% |